XENE

Xenon Pharmaceuticals Inc

38.65
0.12 (0.31%)

Xenon Pharmaceuticals Inc. (XENE) Fundamentals

Founded in 1984, Xilinx is the leader in FPGAs by market share. Its chips are critical in the performance of various devices in the communications, data processing, industrial, consumer, and automotive markets.
SHARE INFORMATION
Market CapUS$ 2,456,683,011
Shares Outstanding63,562,303
Float61,400,000
Percent Float96.6%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 0
Latest Fiscal EPSUS$ -0.63
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions338
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months3,504,426
Institutional Holdings Percent129.2%
Institutional Sold Previous 3 Months4,094,534
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months72,016
Insider Holdings Percent0.1
Insider Sold Previous 3 Months23,710
Insider Shares Owned64,866
TRADING INFO
52 Week HighUS$ 43.57
52 Week LowUS$ 25.92
52 Week High ChangeUS$ 44.87
21 Day Moving AverageUS$ 40.9705
21 Day Extended Moving AverageUS$ 40.1317
50 Day Moving AverageUS$ 38.564
50 Day Extended Moving AverageUS$ 39.2365
200 Day Moving AverageUS$ 37.3775
200 Day Extended Moving AverageUS$ 36.7411
10 Day Average Volume296,827
20 Day Average Volume368,608
30 Day Average Volume392,735
50 Day Average Volume385,981
Alpha0.036862
Beta1.4239
Standard Deviation0.207298
R20.136312
7 Day Price ChangeUS$ -1.86
7 Day Percent Change-4.59%
21 Day Price ChangeUS$ -2.34
21 Day Percent Change-5.71%
30 Day Price ChangeUS$ -1.33
30 Day Percent Change-3.33%
Month to Date Price ChangeUS$ 0.12
Month to Date Percent Change0.31%
Quarter to Date Price ChangeUS$ 2.86
Quarter to Date Percent Change7.99%
180 Day Price ChangeUS$ 1.72
180 Day Percent Change4.66%
200 Day Price ChangeUS$ 4.24
200 Day Percent Change12.32%
Year to Date Price ChangeUS$ -0.78
Year to Date Percent Change-1.98%

Xenon Pharmaceuticals Inc. (XENE) Key Ratios

PROFITABILITY
EBIT Margin-23,356.6%
EBITDA Margin-23,116.8%
Pre-Tax Profit Margin-519.1%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
RevenueUS$ 0
Revenue Per ShareUS$ 0.00
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book3.60
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio23.70
Leverage Ratio1.10
Quick Ratio23.50
Long Term Debt To Capital0.01
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 1,933,639,535
Price to Sales3,801.15
Price to Free Cash0.00
PE High Last 5 Years0.00
Price To Book3.60
Price To Cash Flow-17.70
PE Low Last 5 Years0.00
Price to Tangible Book3.60
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.30
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-23.07
Return on Equity-23.97
Return on Capital-25.15

Xenon Pharmaceuticals Inc. (XENE) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
Auditor-
CEOIan C. Mortimer
Employees153
Last Audit-
CIK0001582313
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address200-3650 Gilmore Way
Burnaby, BC V5G 4W8
Websitehttps://www.xenon-pharma.com
Facsimile+1 604 484-3450
Telephone+1 604 484-3300
Emailinvestors@xenon-pharma.com
Your Recent History
NASDAQ
XENE
Xenon Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20230602 02:49:42